Alpha Cognition Inc. (ACOG) vs Sutro Biopharma, Inc. (STRO)

Alpha Cognition Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Alpha Cognition Inc. and Sutro Biopharma, Inc. are of similar size ($190.0M and $184.0M). Alpha Cognition Inc. has the higher net margin (−137.7% vs −395.3%) and the lower return on invested capital (−144.7% vs 0.00%). Across the 14 metrics below, Alpha Cognition Inc. leads on 8 and Sutro Biopharma, Inc. on 6.

Valuation

Metric ACOG STRO Biotechnology median
P/E n/m n/m 8.50
P/S 11.69 3.94 9.71
P/B 3.37 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 9.04 0.52 9.21
Earnings yield (13.19%) (159.37%) (33.15%)
Free cash flow yield (20.79%) (80.84%) (25.50%)

Profitability

Metric ACOG STRO Biotechnology median
Gross margin 90.37% 100.00% 65.16%
Operating margin (174.70%) (319.57%) 0.00%
Net margin (137.69%) (395.25%) 0.00%
Free cash flow margin (242.99%) (318.63%) 0.00%
Return on equity (49.53%) 266.76% (56.36%)
Return on assets (38.33%) (79.08%) (48.04%)
Return on invested capital (144.65%) 0.00% 0.00%

Growth

Metric ACOG STRO Biotechnology median
Revenue growth (TTM) — (56.25%) 6.02%
EPS growth (last fiscal year) 42.08% 24.02% 30.26%
Revenue growth, 5-year CAGR — 19.12% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 3.32 4.72
Net debt to EBITDA 2.92 0.92 0.96

Dividend

Metric ACOG STRO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACOG STRO Biotechnology median
Market cap 184.02m 190.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack